Affinity Asset Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Hold
2025
Q2
Hold
2023
Q2
Sell
2023
Q1
$1.79M Sell
2022
Q4
$2.25M Buy